Gland Pharma Ltd Share Price Target From 2025 to 2030

Gland Pharma Ltd is a key player in India's pharmaceutical industry, specializing in injectable drugs. With its strong market presence and strategic expansions, investors are keen to understand its future growth trajectory. This blog provides a detailed analysis of Gland Pharma Ltd's share price targets from 2025 to 2030, based on current stock data and expert predictions.

Current Stock Details of Gland Pharma Ltd

Before we dive into future projections, let's examine the latest stock details of Gland Pharma Ltd:

• Open: ₹1,615.90

• Previous Close: ₹1,604.85

• Volume: 60,089

• Value (Lacs): ₹956.86

• VWAP: ₹1,600.56

• Beta: 0.68

• Market Cap: ₹26,235 Crores

• High: ₹1,633.95

• Low: ₹1,580.30

• 52-Week High: ₹2,220.95

• 52-Week Low: ₹1,411.10

• Book Value Per Share: ₹556.81

• Face Value: ₹1

• All-Time High: ₹4,350.00

• All-Time Low: ₹861.00

Gland Pharma Ltd Share Price Target Forecasts from 2025 to 2030

Based on market trends and expert insights, the projected share price targets for Gland Pharma Ltd are as follows:

These estimates indicate steady growth, driven by the company’s expansion strategies and increasing global demand for injectable drugs.

Analysis of Gland Pharma Ltd Share Price Targets

Gland Pharma Ltd Share Price Target 2025

In 2025, Gland Pharma Ltd is expected to trade between ₹1,800 and ₹2,200. Factors contributing to this growth include:

• Expansion of product portfolio.

• Rising demand for injectable pharmaceuticals.

• Increasing exports and global partnerships.

Gland Pharma Ltd Share Price Target 2026

The estimated price range for 2026 is ₹2,100 - ₹2,600. Growth is likely due to:

• Strengthening research and development.

• Higher institutional investments.

• Expansion into new markets.

Gland Pharma Ltd Share Price Target 2027

By 2027, Gland Pharma Ltd's share price is projected between ₹2,400 and ₹3,000. Key drivers include:

• New product launches in international markets.

• Increased manufacturing capacity.

• Enhanced operational efficiency.

Gland Pharma Ltd Share Price Target 2028

For 2028, the estimated share price range is ₹2,800 - ₹3,500. This will be fueled by:

• Stronger financial performance.

• Expansion in Europe and the US.

• Strategic collaborations with biotech firms.

Gland Pharma Ltd Share Price Target 2029

By 2029, the share price is projected between ₹3,200 and ₹3,900. Factors influencing this growth include:

• Increased automation and digital transformation.

• Expansion of biologics manufacturing.

• Growing revenue from exports.

Gland Pharma Ltd Share Price Target 2030

In 2030, Gland Pharma Ltd's share price is expected to reach ₹3,600 - ₹4,500, supported by:

• Sustainable business growth.

• Strong market positioning in injectables.

• Consistent revenue increase from global operations.

Gland Pharma Ltd Shareholding Pattern

The latest shareholding structure of Gland Pharma Ltd is as follows:

• Promoters: 51.83%

• Mutual Funds: 32.37%

• Retail and Others: 8.33%

• Foreign Institutions: 5.04%

• Other Domestic Institutions: 2.43%

This indicates strong promoter confidence and a significant institutional presence, which boosts investor trust.

Factors Affecting Gland Pharma Ltd’s Growth in Share Prices

1. Global Expansion – Increasing presence in international markets will drive revenue growth.

2. Research and Development – Continuous innovation in drug manufacturing will strengthen its competitive edge.

3. Regulatory Approvals – Approvals from the US FDA and other global regulatory bodies will support share price appreciation.

4. Institutional Investments – Growing stake from mutual funds and foreign institutions will provide stability.

5. Industry Growth Trends – Increasing demand for injectables and biologics will benefit the company’s long-term prospects.

FAQs on Gland Pharma Ltd Share Price Target

Q1: What is the Gland Pharma Ltd share price target for 2025?

Answer: The projected share price for 2025 is between ₹1,800 and ₹2,200.

Q2: What is the share price target for Gland Pharma Ltd in 2030?

Answer: By 2030, the share price is expected to range from ₹3,600 to ₹4,500.

Q3: What factors contribute to Gland Pharma Ltd’s share price growth?

Answer: Expansion into new markets, increasing institutional investments, and regulatory approvals are key growth drivers.

Q4: Is Gland Pharma Ltd a good investment for the long term?

Answer: Given its strong market position, increasing demand for injectables, and consistent revenue growth, it appears to be a solid long-term investment.

Conclusion

Gland Pharma Ltd is on a growth trajectory with promising share price targets for 2025 to 2030. Its strong fundamentals, global expansion strategies, and increasing institutional interest make it a valuable stock for long-term investors. As always, investors should conduct thorough research and stay updated on market trends before making investment decisions.